Homepage
Author:
Viva Biotech
Posted Date:
May 29, 2026
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
Viva Biotech
May 29, 2026
From Molecular Design to Scalable Execution: The Combined Impact of AI and Flow Chemistry
Viva Biotech
May 24, 2026
Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up
Viva Biotech
May 21, 2026
Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the ‘Lab-in-the-Loop’ with NVIDIA
Viva Biotech
May 19, 2026
